Phase 2 study of LIPO-202 in patients with central abdominal bulging

Trial Profile

Phase 2 study of LIPO-202 in patients with central abdominal bulging

Planning
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2016

At a glance

  • Drugs Salmeterol (Primary)
  • Indications Subcutaneous fat disorders
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Neothetics
  • Most Recent Events

    • 10 Nov 2016 According to a Neothetics media release, based on the results of a trial (see profile 269605) in patients with fat deposits under the chin (submental fat) company will initiate this study.
    • 11 Aug 2016 According to Neothetics media release, company plans to initiate this trial in the first quarter of 2017 and report top-line data in third quarter of 2017
    • 30 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top